On 16 August, Ashish Adukia was appointed as the global Chief Financial Officer (CFO), and key managerial personnel of Cipla Ltd approval was given by the board of directors (BOD). Dinesh Jain, the new appointment, will relieve the additional responsibility of the interim CFO. He will continue with the company as senior vice president and head of corporate finance. Ashish Adukia is a Chartered Accountant (CA) and MMS (Finance) from JBIMS. In 2017, he featured in Fortune India’s 40 under 40 lists.

• Andhra Pradesh Approves Rs 500 Crore Port, Shipbuilding Cluster
• Amazon Eyes Faster Content Production With AI
• Why India Is Emerging as a Second Home for Multinationals
• Indigo Shares Slip 2% as CCI Orders Further Investigation 
• Concord Control Wins KAVACH 4.0 Order; Stock Jumps 4%

Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.

The consolidated net profit of Cipla Ltd has slipped 4 per cent to Rs 686.40 crore on a 2.3 per cent decline in total revenue from operations to Rs 5,375.19 crore in Apr-Jun quarter of FY23 over the same period of last year. Also, the stock of Cipla Ltd went down by 0.18 per cent to Rs 1,032 on the Bombay Stock Exchange (BSE).